检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:郭晓青[1] 刘艳凤[2] 郭瑞霞[3] 张立玮[1] 王士杰[1]
机构地区:[1]河北医科大学第四医院内镜室,石家庄050011 [2]河北省唐山市人民医院 [3]河北省石家庄市第六医院
出 处:《现代预防医学》2008年第14期2751-2753,2755,共4页Modern Preventive Medicine
摘 要:[目的]研究食管癌变过程中p16和FHIT基因甲基化与蛋白表达的关系。[方法]应用甲基化特异性聚合酶链反应方法,对44例癌前病变、14例原位癌、37例浸润癌和10例慢性食管炎共105例患者组织DNA进行了p16和FHIT基因甲基化检测,应用免疫组织化学的方法检测了相应组织两基因蛋白表达情况,并进行相关性分析。[结果]在105例患者组织中,随着病变程度的加重,p16和FHIT基因甲基化频率和蛋白缺失率均呈逐渐增加的趋势,重度不典型增生、鳞状细胞原位癌及浸润癌的甲基化频率和蛋白表达缺失率均显著高于黏膜慢性炎症组,且p16和FHIT基因甲基化与蛋白失表达密切相关。[结论]p16和FHIT蛋白表达缺失是食管癌以及癌前病变发生的一个早期事件;p16和FHIT基因可能通过启动子区甲基化失活参与了食管癌的发生发展过程。[ Objective] To study the relationship of p16 and FHIT methylafion with the protein expression in the esophageal carcinogenesis. [Methods] Methylated-specifie PCR (MSP) was performed to detect the p16 and FHIT methylfion status in 44 eases of esophageal preeancerous lesions, 14 carcinoma in situ (CIS), 37 infiltrated carcinoma and 10 chronic esophatitis (CE). Loss of protein expression of p16 and FHIT was detected immunohistochemically and the relationship of methylation and loss of protein expression was evaluated with correlation analysis. [Results] Among 105 cases, the methylation frequencies and loss of protein expression of both genes were showed to be increasing tendency with the aggravation of the disease. The methylation frequencies and loss of protein expression of p16 and FHIT in the severe dysplasia, CIS and infiltrated carcinoma groups were apparendy higher than that in the CE. The methylation status of p16 and FHIT showed signifieandy association with the expression of proteinum. [Conclusion] Loss of protein expression of p16 and FHIT is an early event in the esophageal carcinogenesis. Inactivation of p16 and FHIT might play an important role in the progression of esophageal eaneer by promoting the inaetivation of methylation.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.173